Cancer Family
Secondary Malignant Neoplasm
CI-CAN-00000346SMNExplore in graph →
4,275 active trials56 approved drugs532 evidence items
- NCIt
- C4968
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000346SMNExplore in graph →
Clinical trials
14,674 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03090815 | Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma | unknown | — | 100 | The University of Hong KongOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT03084380 | Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 20 | Xinqiao Hospital of ChongqingOTHER | 1 | Mar 20, 2017 | clinicaltrials |
| NCT03082378 | Central Obesity and Hepatocellular Carcinoma | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT01869088 | TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma | unknown | Phase 3 | 266 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2017 | clinicaltrials |
| NCT03071705 | Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma | unknown | N/A | 120 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT03071900 | CTC Detection Rate in SCCHN With a in Vivo Device | unknown | N/A | 50 | Nanjing Tongren HospitalOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT02943044 | Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma | unknown | — | 50 | Zenalux Biomedical, Inc.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03069508 | Clemizole HCl for Subjects With Hepatocellular Carcinoma | unknown | Phase 2 | 12 | Eiger Group International, Inc.INDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT03066557 | Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma | unknown | N/A | 80 | Jiangsu Cancer Institute & HospitalOTHER | 0 | Feb 28, 2017 | clinicaltrials |
| NCT01216527 | Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer | unknown | Phase 3 | 430 | Sun Yat-sen UniversityOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT02282267 | Blood Detection of EGFR Mutation For Iressa Treatment(Benefit) | unknown | N/A | 188 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02936856 | Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications(RDSA) | unknown | N/A | 200 | Guangxi Medical UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT03063554 | EUS BD vs ERCP TP for Pancreatic Cancer(BILPAL) | unknown | N/A | 120 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02956772 | Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 2 | 190 | Hunan Provincial People's HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02783261 | Prospective Post Y90 Liver Hypertrophy | unknown | — | 25 | Singapore General HospitalOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT01665417 | Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | unknown | Phase 4 | 100 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 8, 2017 | clinicaltrials |
| NCT03046979 | Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)(HCC) | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT01731925 | A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors(SUNLAND) | unknown | Phase 2 | 44 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jan 31, 2017 | clinicaltrials |
| NCT03029858 | PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients(ATHENE) | unknown | — | 155 | Guangdong Association of Clinical TrialsOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT03025724 | Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ | unknown | N/A | 40 | Rhode Island HospitalOTHER | 0 | Jan 19, 2017 | clinicaltrials |
| NCT02446795 | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial(QUASAR) | unknown | Phase 1 / Phase 2 | 104 | Consorzio OncotechOTHER | 1 | Jan 18, 2017 | clinicaltrials |
| NCT03020342 | HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC | unknown | — | 50 | National Taiwan University HospitalOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT01966133 | TACE as an Adjuvant Therapy After Hepatectomy for HCC | unknown | Phase 3 | 280 | Jia FanOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Dec 28, 2016 | clinicaltrials |
| NCT02985255 | Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue | unknown | Phase 2 | 30 | HealthCare Global Enterprise Ltd.INDUSTRY | 1 | Dec 7, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02348450 | Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer | unknown | Phase 4 | 308 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02980809 | Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer | unknown | Phase 2 | 60 | First Hospitals affiliated to the China PLA General HospitalOTHER_GOV | 0 | Dec 2, 2016 | clinicaltrials |
| NCT01504997 | Phase II Study for Robot Assisted Distal Gastrectomy(RADGphaseII) | unknown | Phase 2 | 23 | Shizuoka Cancer CenterOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02787447 | Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy | unknown | Phase 2 | 46 | First People's Hospital of HangzhouOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT02787473 | A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer | unknown | Phase 2 | 54 | First People's Hospital of HangzhouOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT02972320 | Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic | unknown | Phase 2 | 60 | Yunpeng LiuOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02970786 | Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans | unknown | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Nov 22, 2016 | clinicaltrials |
| NCT02755675 | uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung | unknown | Phase 2 | 120 | Rigshospitalet, DenmarkOTHER | 1 | Nov 21, 2016 | clinicaltrials |
| NCT02964351 | microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer | unknown | — | 120 | Assuta Medical CenterOTHER | 0 | Nov 16, 2016 | clinicaltrials |
| NCT02952612 | Active Surveillance of Papillary Thyroid Microcarcinoma | unknown | — | 300 | Dong Jun LimOTHER | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02959151 | A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy | unknown | Phase 1 / Phase 2 | 20 | Shanghai GeneChem Co., Ltd.INDUSTRY | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02738697 | Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection | unknown | Phase 3 | 290 | Sun Yat-sen UniversityOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02951897 | Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma(CTCs detection) | unknown | N/A | 120 | Third Military Medical UniversityOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02951637 | Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial | unknown | Phase 2 | 300 | Shanghai Chest HospitalOTHER | 0 | Nov 1, 2016 | clinicaltrials |
| NCT00606385 | Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC(HCC) | unknown | N/A | 84 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02590510 | Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis | unknown | Phase 4 | 50 | Hui BuOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02946216 | ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC | unknown | — | 200 | First People's Hospital of HangzhouOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02813096 | Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients | unknown | N/A | 500 | Guangxi Medical UniversityOTHER | 0 | Oct 25, 2016 | clinicaltrials |
| NCT02943798 | Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma | unknown | Phase 2 | 118 | Shanghai Chest HospitalOTHER | 0 | Oct 25, 2016 | clinicaltrials |
| NCT02523053 | Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients | unknown | N/A | 160 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Oct 21, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Mar 27, 2017source: clinicaltrials